Prevalence of Soft Tissue Sarcoma (STS) Subtypes in the US, Risk of Metastases at Diagnosis, and Survival Outcomes.
Less than 1 min read
Scroll
Soft tissue sarcomas (STS) are heterogeneous malignancies with diverse clinical presentations and outcomes.
This study examines the prevalence, metastatic risk, and survival impact of various STS subtypes. By characterizing the disease landscape, we aim to inform treatment strategies, resource allocation, and clinical trial design, ultimately improving patient outcomes.
Click here to download our White paper.
Jump to a slide with the slide dots.
ASCO24: The Evolving Role of Biomarkers in Treatment-Resistant and Refractory Cancers
Physicians and healthcare professionals (HCPs) struggle with the vast amounts of new information provided to them, related to patient care. As...
Read moreAI’s transformative influence on medical communications
Physicians and healthcare professionals (HCPs) struggle with the vast amounts of new information provided to them, related to patient care. As...
Read more